Geneos Wealth Management’s Twist Bioscience TWST Stock Holding History

Geneos Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Sell	5,300 -1,750	-25%	-$114K	0.01%	708
2026 Q1	$335K	Sell	7,050 -1,900	-21%	-$85.2K	0.01%	806
2025 Q4	$284K	Buy	8,950 +3,500	+64%	+$109K	0.01%	815
2025 Q3	$153K	Buy	5,450 +2,800	+106%	+$84.8K	﹤0.01%	997
2025 Q2	$97.5K	Buy	+2,650	New	+$91.6K	﹤0.01%	1267
2022 Q1	–	Sell	-2,825	Closed	-$218K	–	2983
2021 Q4	$218K	Sell	2,825 -500	-15%	-$51.3K	0.01%	827
2021 Q3	$350K	Buy	3,325 +900	+37%	+$103K	0.01%	665
2021 Q2	$318K	Buy	2,425 +1,800	+288%	+$209K	0.01%	673
2021 Q1	$83K	Sell	625 -750	-55%	-$114K	﹤0.01%	1383
2020 Q4	$159K	Buy	+1,375	New	+$153K	0.01%	922

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geneos Wealth Management's TWST Position: Q2 2026 in Review

Geneos Wealth Management reduced its Twist Bioscience (TWST) stake by 25% in Q2 2026, selling an estimated $114K and leaving 5,300 shares worth $545K. The position accounts for 0.01% of the portfolio, ranked #708.

Geneos Wealth Management first reported a position in TWST in Q4 2020 and has held it in 10 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Geneos Wealth Management held 5,300 shares of Twist Bioscience worth $545K as of Q2 2026.
Geneos Wealth Management sold 1,750 Twist Bioscience shares in Q2 2026, an estimated $114K.
Twist Bioscience made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #708 holding.
Geneos Wealth Management first reported a position in Twist Bioscience in Q4 2020 and has held it in 10 quarters since.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.